Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LLamasoft is a leading provider of AI-powered supply chain design and analytics software, acquired by Coupa Software in 2020 for approximately $1.5 billion. The company's platform, llama.ai, enables organizations to create "digital twins" of their supply chains to model, optimize, and simulate various scenarios for better decision-making. In the life sciences and healthcare sectors, LLamasoft's solutions are widely used by pharmaceutical companies and global health organizations to optimize the distribution of medicines, vaccines, and medical supplies. Its technology played a critical role in COVID-19 vaccine logistics and continues to support global health initiatives like TB and malaria treatment distribution. The company serves a significant portion of the Fortune 100, including many of the world's largest pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LLamasoft.